Chronic Migraine Epidemiology and Outcomes Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Allergan
ClinicalTrials.gov Identifier:
NCT01648530
First received: July 20, 2012
Last updated: January 17, 2014
Last verified: January 2014
  Purpose

This is a population internet-based study to characterize migraine clinical course and impact on family.


Condition Intervention
Migraine Disorders
Other: No Treatment

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Allergan:

Primary Outcome Measures:
  • Migraine Disability Assessment (MIDAS) [ Time Frame: 13 Months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Subject Quality of Life Questionnaire [ Time Frame: 13 Months ] [ Designated as safety issue: No ]

Enrollment: 16789
Study Start Date: July 2012
Study Completion Date: November 2013
Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Migraine
Subjects with migraine and household members
Other: No Treatment
No Treatment

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects with chronic migraine

Criteria

Inclusion Criteria:

  • History of migraine
  • U.S. Member of Survey Panel
  • Household member of study participant
  • Ability to complete internet-based questionnaires

Exclusion Criteria:

  • No access to internet
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01648530

Sponsors and Collaborators
Allergan
Investigators
Study Director: Medical Director Allergan
  More Information

No publications provided

Responsible Party: Allergan
ClinicalTrials.gov Identifier: NCT01648530     History of Changes
Other Study ID Numbers: GMA-BTX-12-470
Study First Received: July 20, 2012
Last Updated: January 17, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Migraine Disorders
Headache Disorders, Primary
Headache Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on April 16, 2014